Skip to main content
SpringerLink
Log in

Anakinra/tisagenlecleucel/tocilizumab

Various toxicities: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Dreyzin A, et al. Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults. Pediatric Hematology and Oncology 39: 370-378, No. 4, May 2022. Available from: URL: http://doi.org/10.1080/08880018.2021.1988012

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anakinra/tisagenlecleucel/tocilizumab. Reactions Weekly 1912, 35 (2022). https://doi.org/10.1007/s40278-022-17738-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-17738-1

Search

Navigation